Nature Medicine
11, 578 (2005)
doi:10.1038/nm0505-578b
CORRIGENDUM: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemiaTakuya Matsunaga, Naofumi Takemoto, Tsutomu Sato, Rishu Takimoto, Ikuta Tanaka, Akihito Fujimi, Takehide Akiyama, Hiroyuki Kuroda, Yutaka Kawano, Masayoshi Kobune, Junji Kato, Yasuo Hirayama, Sumio Sakamaki, Kyuhei Kohda, Kensuke Miyake
& Yoshiro NiitsuNat. Med.
9, 1158−1165 (2003)
Two sentences in this article appeared incorrectly. On page 1164, in the eighth paragraph, the third sentence should read "To the U937-transplanted SCID mice, 1 mg of either SG/17, YN907 or vehicle was injected intravenously, and 20 mg of either AraC or normal saline was injected intraperitoneally on day 7 of transplantation." On page 1164, in the eighth paragraph, the fourth sentence should read "To NOD-SCID mice transplanted with patients' leukemic cells, 2 mg of either SG/17 or YN907 was injected intravenously, and 40 mg of either AraC or normal saline was injected intraperioneally on days 3 and 4 of transplantation."
|
